Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy

Background: Patients using dual antiplatelet therapy after percutaneous coronary intervention are at risk for bleeding. It is currently unknown whether thrombin generation can be used to identify patients receiving dual antiplatelet therapy with increased bleeding risk. Objectives: To investigate wh...

Descripción completa

Detalles Bibliográficos
Autores principales: de Breet, C. P. D. M., Zwaveling, S., Vries, M. J. A., van Oerle, R. G., Henskens, Y. M. C., van't Hof, A. W. J., van der Meijden, P. E. J., Veenstra, L., ten Cate, H., Olie, R. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224526/
https://www.ncbi.nlm.nih.gov/pubmed/34179143
http://dx.doi.org/10.3389/fcvm.2021.679934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224526/
https://www.ncbi.nlm.nih.gov/pubmed/34179143
http://dx.doi.org/10.3389/fcvm.2021.679934

Ejemplares similares